James Gordon

Stock Analyst at JP Morgan

(1.17)

# 2,580

Out of 4,479 analysts

5

Total ratings

50%

Success rate

2.52%

Average return

Main Sectors:

Top Industries:

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ARGX argenx SE	Maintains: Overweight	$560 → $500	$435.49	+14.81%	3	May 13, 2024
	MOR MorphoSys AG	Downgrades: Neutral	n/a	$18.10	-	1	Jun 11, 2021
	FGEN FibroGen	Upgrades: Neutral	n/a	$0.74	-	1	Apr 7, 2021

argenx SE

May 13, 2024

Maintains: Overweight

Price Target: $560 → $500

Current: $435.49

Upside: +14.81%

MorphoSys AG

Jun 11, 2021

Downgrades: Neutral

Price Target: n/a

Current: $18.10

Upside: -

FibroGen

Apr 7, 2021

Upgrades: Neutral

Price Target: n/a

Current: $0.74

Upside: -